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Institoris A, Snipes JA, Katakam PV, Domoki F, Boda K,
Bari F, Busija DW. Impaired vascular responses of insulin-
resistant rats after mild subarachnoid hemorrhage. Am J Physiol
Heart Circ Physiol 300: H2080 –H2087, 2011. First published
March 18, 2011; doi:10.1152/ajpheart.01169.2010.—Insulin resis-
tance (IR) impairs cerebrovascular responses to several stimuli in
Zucker obese (ZO) rats. However, cerebral artery responses after
subarachnoid hemorrhage (SAH) have not been described in IR. We
hypothesized that IR worsens vascular reactions after a mild SAH.
Hemolyzed blood (300 l) or saline was infused (10 l/min) into the
cisterna magna of 11–13-wk-old ZO (n  25) and Zucker lean (ZL)
rats (n  25). One day later, dilator responses of the basilar artery
(BA) and its side branch (BA-Br) to acetylcholine (ACh, 106 M),
cromakalim (107 M, 106 M), and sodium nitroprusside (107 M)
were recorded with intravital videomicroscopy. The baseline diameter
of the BA was increased both in the ZO and ZL rats 24 h after the
hemolysate injection. Saline-injected ZO animals showed reduced
dilation to ACh (BA  9  3 vs. 22  4%; and BA-Br  23  5 vs.
37  7%) compared with ZL rats. Hemolysate injection blunted the
response to ACh in both the ZO (BA  4  2%; and BA-Br  12 
3%) and ZL (BA  7  2%; and BA-Br  11  3%) rats.
Cromakalim (106 M)-induced dilation was significantly reduced in
the hemolysate-injected ZO animals compared with the saline control
(BA  13  3 vs. 26  5%; and BA-Br  28  8 vs. 44  9%) and
in the hemolysate-injected ZL rats compared with their saline control
(BA  24  4 vs. 32  4%; but not BA-Br  39  6 vs. 59  9%).
No significant difference in sodium nitroprusside reactivity was ob-
served. Western blot analysis of the BA showed a lower baseline level
of neuronal nitric oxide synthase expression and an enhanced cyclo-
oxygenase-2 level in the hemolysate-injected ZO animals. In sum-
mary, cerebrovascular reactivity to both endothelium-dependent and
-independent stimuli is severely compromised by SAH in IR animals.
cerebral circulation; endothelium; vascular smooth muscle; nitric
oxide; Zucker obese rats; adenosine 5=-triphosphate-sensitive potas-
sium channels; insulin resistance
INSULIN RESISTANCE (IR), a normally “silent” and undetected
predecessor of type II diabetes, is a major risk factor for the
development of cerebral vascular disease and neurological
pathologies such as strokes. There is an increased prevalence
of both ischemic and hemorrhagic strokes in IR individuals (4,
14, 45, 56), and stroke patients with type 2 diabetes experience
a slower recovery of neurological function and a higher mor-
tality (2, 3, 23, 55). The major underlying basis for augmented
neurological damage could be the IR-related dysfunction of the
cerebral vasculature. The leptin receptor-deficient Zucker
obese (ZO) rat is a commonly used animal model to study IR.
The 11–13-wk-old prediabetic ZO rat is characterized by
obesity, normal blood pressure, and elevated plasma insulin
and lipid levels, without an increase of glucose level. Our
laboratory made the original observations that dilator re-
sponses of cerebral arteries to physiologically relevant fac-
tors are reduced in ZO animals (10, 16, 17, 19). For
example, the dilator responses of cerebral arteries mediated
by endogenous nitric oxide (NO) production and activation
of vascular smooth muscle K channels are impaired in ZO
rats (10, 17). Moreover, this animal strain appears to be
more susceptible to an ischemic brain insult than the Zucker
lean (ZL) counterpart (41).
Subarachnoid hemorrhage (SAH) is responsible for 5–10%
of all strokes and results in a high rate (50–70%) of mortality
(46). The most critical complication of SAH is cerebral vaso-
spasm associated with impaired dilator mechanisms in cerebral
arteries. Blood injection into the cisterna magna is a widely
used experimental method (47) to investigate the vascular
complications of SAH. For several days after the injection of
blood, endothelium-derived NO-mediated dilation, the func-
tion of several types of K channels, and the activity of
soluble guanylate cyclase (sGC) dilation have been found to
be impaired in the basilar artery (47). However, the relax-
ation to the ATP-sensitive K (KATP) channel openers
aprikalim and cromakalim have been shown to be selec-
tively augmented (48, 49, 58).
Several clinical studies focused on the relationship of type 2
diabetes and hyperglycemia to SAH outcome (6, 15, 22);
however, to our current knowledge, no studies explored the
outcome of SAH in patients with IR or metabolic syndrome
compared with patients with no metabolic disease. While the
effects of IR or SAH on cerebral arteries have been examined
individually and the mechanisms of vascular dysfunction show
similarities, we are unaware of studies examining alterations of
cerebrovascular responses following intracisternal blood injec-
tion in IR rats. Based on the previously introduced studies, it is
very probable that the combination of IR and SAH eliminates
endothelium-related dilation, whereas it is hard to predict their
counteracting effects on KATP channel-mediated relaxation.
Therefore, we hypothesized that even a mild SAH creates
vasospasm in IR rats and that the dilator responses of the
basilar artery and one of its side branches in response to
applications of acetylcholine (endothelium-derived NO-medi-
ated dilator), cromakalim (opener of the KATP channel on the
vascular smooth muscle), and sodium nitroprusside (direct
sGC activator) 24 h after intracisternal injection of heterolo-
gous hemolyzed blood in ZO is more severely compromised
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compared with ZL rats. Furthermore, we quantified the
changes of endothelial and neuronal NO synthase (eNOS and
nNOS, respectively) levels and cyclooxygenase-2 (COX-2)
enzyme expression in the major cerebral arteries, because the
change of these enzyme levels may indicate the basis of
damaged vascular function (35, 44, 50).
MATERIALS AND METHODS
The experimental protocol was approved by the Animal Care and
Use Committee at Wake Forest University Health Sciences (Winston-
Salem, NC). ZO (11–13 wk old; n  25) and ZL (11–14 wk old; n 
25) rats (Harlan, Indianapolis, IN) were used for the study.
Intracisternal hemolysate injection. One ZO and one ZL animal
were used to obtain 6–6 ml donor blood via cardiac puncture after
which the animals were euthanized. The samples were anticoagulated
with heparin (1:10). To hemolyze and store the samples, aliquots were
put on 80°C. They were later thawed and used for intracisternal
hemolysate injection. The remaining spontaneously breathing rats
were anesthetized (5% induction; and 1.7–2.5% maintenance) with
isoflurane (Florine) mixed with 40% O2-60% N2O, and the rectal
temperature was monitored and maintained on 37°C. The heads were
fixed in a stereotaxic frame tilted 30° forward to aid in exposing the
cisterna magna. Lubricating ointment gel was applied to the eyes to
protect them from drying out, and ears were smeared with lidocaine
gel to reduce potential discomfort. The scruff was shaved and disin-
fected, and after a midline incision, the medial neck muscles were
separated and retracted to expose the atlanto-occipital membrane. The
tail was clipped to obtain blood, and blood glucose level was analyzed
immediately by a handheld blood glucose meter kit (Mckesson True
Track). Cerebrospinal fluid (80–200 l) was then carefully withdrawn
from the cisterna magna 2 mm below the occipital bone with a
Hamilton syringe. A 30-gauge needle connected to a catheter was
introduced 2 mm deep into the same hole, and 300 l heterologous
hemolyzed blood was injected into the cisterna magna with an
infusion pump for 30 min (10 l/min).
Subsequently, the rats were kept in the same position for an
additional 30 min to facilitate the settling of blood products in the
basal cisterns, and the catheter was removed and the muscle and skin
were sutured. To prevent volume depletion, the rats received 2 ml/kg
saline subcutaneously and returned to their cages for 24 h with free
access to food and water. The following experimental groups were
created: ZL rats with intracisternal saline (LS) or blood (LB) injection
and ZO rats with saline (OS) or blood (OB) injection.
Vascular reactivity measurement. Twenty-four hours after the in-
jection, the animals were reanesthetized with pentobarbital sodium
(90–100 mg/kg ip) and mechanically ventilated via tracheotomy with
O2-enriched room air. The end-tidal partial pressure of CO2 was
continuously recorded (Microcapnograph CI240, Columbia Instru-
ments) and was kept between 38–40 mmHg. The body temperature
was monitored with a rectal probe and maintained around 37°C with
a heating blanket. A catheter was placed into the femoral artery to
monitor arterial blood pressure and to obtain arterial blood samples.
The femoral vein was also cannulated to supplement anesthetics (20
mg·kg1·h1) with an infusion pump. The rats were arranged in a
supine position and the heads secured into place with a stereotaxic
apparatus. After carefully separating and retracting the neck muscles
in the midline, we performed a ventral craniotomy 2–3 mm in
diameter with a drill over the base of the skull. Inflow and outflow
ports were placed above the window to allow the superfusion of
artificial cerebrospinal fluid at a rate of 3 ml/min. The membranes
were then removed from over the basilar artery with fine pincers and
a bent 30-gauge needle. The basilar artery and a side branch were
visualized by a surgical microscope equipped with a charge-coupled
device camera connected to a computer, and the diameters were
analyzed using the Scion Image Software (Scion, Frederick, MD,
USA). The dilator responses of the basilar artery and the side branch
to acetylcholine (106 M), cromakalim (107 M, 106 M), and
sodium-nitroprusside (107 M) were recorded at a sampling rate of 1
image/2 s. Acetylcholine was purchased from Sigma (St. Louis, MO),
and cromakalim was bought from Tocris (Ellisville, MO). At the end
of the experiment, the animals were euthanized with an overdose of
anesthesia, and the main cerebral arteries (basilar artery and 2 ante-
rior, 2 media, and 2 posterior cerebral arteries) were cleaned, re-
moved, and stored at 20°C in an extraction buffer for Western blot
analysis.
Western blot analysis. As previously described (24, 31), Western
blot analyses for eNOS, nNOS, and COX-2 were performed using
appropriate antibodies. The same amount of extracted protein from
whole tissue homogenates of cerebral arteries was loaded for SDS-
PAGE/immunoblot analysis. Each immunoband intensity was nor-
malized to the corresponding immunoband intensity of -actin, which
was used as an internal control. The following antibodies were used:
anti-eNOS (BD Bioscience), anti-nNOS (Sigma-Aldrich), and anti-
COX-2 (Cayman) and a secondary anti-mouse antibody (Jackson
Immunoresearch).
Data analysis and statistics. Values are means  SE. Vascular
responses were expressed as the maximal diameter change from
baseline in percentage during the drug applications. The program
SPSS17 was used for all statistical analysis. The diameters of the
basilar arteries were compared with two-way ANOVA. Vascular
response data were normalized by logarithmic transformation, which
was followed by two-way ANOVA. Survival rates were compared
with a Mann-Whitney nonparametric U-test, whereas other physio-
logical parameters were compared with one-way ANOVA. For pair-
wise comparison, least significant difference post hoc test was applied
in all cases.
RESULTS
Experimental conditions during surgical interventions. The
intracisternal injection of hemolysate caused a significantly
lower survival rate in the OB (57 vs. 100%) than in the LB (62
vs. 82%) rats compared with their saline-injected control group
(OS and LS, respectively) (P  0.05) (Table 1). Isoflurane
anesthesia induced elevated plasma glucose levels in all the
groups because of its described hyperglycemia-generating ef-
fect (33) (Table 1). Under pentobarbital sodium anesthesia, OS
and OB animals showed significantly higher glucose levels
(162  24 and 179  34 mg/dl, respectively) than the LS and
LB groups (103  13 and 82  5 mg/dl, respectively) (P 
0.05), although they were still below the clinically defined
“hyperglycemic threshold” (200 mg/dl) (Table 1). All other
parameters were within the physiological range (Table 1).
Baseline diameter of the basilar artery 24 h after intracis-
ternal hemolysate injection. Injection of blood products but not
saline into the cisterna magna resulted in the observation of
slight discoloration around the basilar artery upon the opening
of the dura mater but without the presence of obvious blood
clots. The baseline diameters of the basilar arteries were
determined before the recording of the dilatory responses by
two independent observers with identical results. The diame-
ters in the LB (n  8; 201  12 m) and OB (n  8; 206 
8 m) groups were significantly larger (P  0.05) than that of
the LS (n  9; 179  8 m) and OS (n  10; 183  7 m)
groups (Fig. 1). No difference in the baseline diameter of the
side branch was found between the groups (LS  80.43 
15.25, LB  82.66  20.57, OS  79.87  12.14, and OB 
87.46  16.96 m; means  SD) (Fig. 1).
Vascular responses of the basilar artery and side branch.
Acetylcholine (106 M) produced a 22  4% dilation of the
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basilar artery and 37  7% dilation of the side branch in the
LS group (Fig. 2, A and B). This response was significantly
less in the basilar artery of the OS group (9  3%) (P 
0.05) and mildly reduced in the side branch (23  5%).
Hemolysate injection diminished the response of the LB
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Fig. 1. The internal diameter of the basilar artery (BA) 24 h after intracisternal
hemolysate injection in Zucker lean (ZL) and Zucker obese (ZO) rats. ZL
saline-injected group (LS, n  8), ZL blood-injected group (LB, n  9), ZO
saline-injected group (OS, n  8), and ZO blood-injected group (OB, n  10)
are shown. *P  0.05, blood vs. saline.
Fig. 2. Acetylcholine (106 M) response of the BA (A) and its side branch (B)
24 h after intracisternal hemolysate or saline injection in ZO and ZL rats. Data
are expressed as percent change from baseline diameter (means  SE). LS
(n  8), LB (n  8), OS (n  9), and OB (n  8) groups are shown. *P 
0.05, blood vs. saline; #P  0.05, obese vs. lean.
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group both in the basilar artery (7  2%) and in the side
branch (11  3%) (P  0.05). The impaired dilation of the
OB group was more pronounced in the basilar artery (4 
2%) but was also significant in the side branch (12  3%)
(P  0.05).
Cromakalim at 107 M and 106 M dilated both the
basilar artery (Fig. 3, A–C) and the side branch (Fig. 3, B–D)
of the LS group in a dose-dependent fashion. The vascular
responses to the lower dose (107 M) of cromakalim were
significantly reduced in the basilar artery of the ZO groups
(OS and OB) compared with the counterpart ZL groups (LS
and LB) (P  0.05), whereas the hemolysate injection did
not change the basilar artery dilation in either the LB (11 
4%) versus the LS (10  5%) group and in the OB (4  2%)
versus the OS (5  1%) group (Fig. 3, A and B). A similar
but not significant tendency was found for the response of
the side branch. The OS (9  2%) and OB (11  4%)
groups showed less relaxation compared with the LS (16 
2%) and LB (186%) groups, whereas no change was found
in the side branch reactivity after hemolysate injection to
low-dose cromakalim. In contrast, the basilar artery response
to the higher dose (106 M) of cromakalim was significantly
blunted in the OB (13  3%) compared with the OS (26  5%)
group (P 0.05), whereas the dilation in the LB group (24 4%)
was not considerably less than in the LS group (32  4%).
The side branch also showed a significantly reduced relax-
ation in the obese groups (OS  44  9, and OB  28 
8%) versus the lean groups (LS  59  8, and LB  39 
6%) (P  0.05), whereas the response of the side branches
remained unaltered by the hemolysate injection.
While there was a tendency for a reduced vascular respon-
siveness to sodium nitroprusside in the OS and OB groups
compared with the LS and LB groups, respectively, and the
power of the statistical analysis was low (0.055–0.341), the
difference was not significant (Fig. 4).
Protein expression of the cerebral vessels after intracister-
nal hemolysate injection. There were no differences in eNOS
levels among the four groups (Fig. 5A). The eNOS enzyme
levels in the LS and OS animals were the same (100  12 and
111 12%, respectively), and the hemolysate injection did not
change the eNOS expression (109  17 for LB and 122  9%
for OB group). However, nNOS expression was significantly
reduced in the OS (n  3; 63  6%) compared with the LS
(n  3; 100  9%) groups (P  0.01). Intracisternal hemoly-
sate injection had no effect on the vascular nNOS levels in the
LB (n 4; 104 11%) and the OB (n 4; 66 10%) groups
(Fig. 5B).
The COX-2 expression in the cerebral vessels of LS (100 
14%; n  4) and OS (96  16%; n  4) rats was similar (Fig.
5C). The LB showed only a modest increase in vascular
COX-2 expression (136  17%; n  4), whereas the OB rats
presented a significant twofold elevation in the protein level
(n  5; 205  35%) (P  0.05).
Fig. 3. Dose-dependent responses of the BA (A–C) and the side branch (B–D) of ZO and ZL rats to 107 M (A and B) and 106 M (C and D) cromakalim 24
h after intracisternal hemolysate or saline injection. Data are expressed as percent changes from baseline diameter (means  SE). LS (n  8), LB (n  8), OS
(n  10), and OB (n  7) groups are shown. *P  0.05, blood vs. saline; #P  0.05 obese vs. lean.
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DISCUSSION
The major finding of the study is that the adverse effects of
SAH on cerebral vascular dilator responses are exacerbated in
insulin-resistant animals. Thus both endothelial-dependent and
-independent responses are more impaired following a single
injection of hemolyzed blood into the cisterna magna in ZO
compared with ZL rats. While the mechanisms involved are
not entirely clear, we suggest that an increase in COX-2 levels
is a potential contributor for impaired cerebral vascular respon-
siveness. Nonetheless, the translational implication is that in-
sulin-resistant individuals are at risk for exaggerated negative
effects of perivascular blood around cerebral resistance ves-
sels, and this factor should be taken into consideration during
treatment of people suffering from SAH. The single injection
of 300 l heterologous hemolysate 1 day before examination
did not create vasospasm in the basilar artery of ZO and ZL
rats but rather slightly increased the baseline diameter. We
have observed similar results in a previous study in piglets,
where a single injection of blood products around the
cortical arteries did not induce vasospasm but inhibited
dilator responses to arterial hypercapnia and hypotension
but not to isoproterenol (8).
Delayed vasoconstriction is a widely known and severe
complication of SAH (32, 34, 46, 47, 54, 57) in people, but its
presence in experimental animals is dependent on technical
issues such as timing and number of blood injections. For
example, a double injection model using fresh, nonhemolyzed
autologous blood is normally required to induce basilar artery
vasospasm in rats and dogs (25–28, 39). However, vasospasm
takes several days to develop, and it is possible, but unex-
plored, that cerebral vascular responses in people are impaired
even during the prespasm period. Furthermore, the reduced
baseline diameter of the vasospastic arteries as well as the
underlying pathology in SAH would be expected to exacerbate
the derangement of the vascular effects of the basilar to dilator
agents.
Acetylcholine elicited smaller responses in the OS than in
the LS rats, but the responses to the NO donor sodium nitro-
prusside were not statistically different among the four groups.
Although no changes were seen in eNOS abundance and the
nNOS abundance was lower, the reduced vasodilation, depen-
dent on endogenous NO, is likely due to reduced NO synthase
activity or low NO bioavailability via the well-known NO
scavenging action of oxygen free radicals (19, 21). Impaired
function and expression of acetylcholine receptors on vascular
endothelial cells or the altered reactivity of smooth muscle
cells to the released NO may be responsible for the difference
of acetylcholine-mediated dilation in the ZO versus the ZL rats
in SAH, but further systematic investigations are needed to
clarify the molecular counteraction of IR and SAH. However,
this is the first study to show that the reduced dilator response
of the cerebral arteries of ZO rats to acetylcholine is correlated
with a lower expression of nNOS. Our results are supported by
Cellek et al. (12) who have previously shown that nNOS-
expressing perivascular neurons around the basilar artery are
progressively degenerated in streptozotocin-induced diabetic
rats. While nNOS is normally localized to perivascular nerves
associated with cerebral arteries and has several well-defined
effects on cerebral vascular tone (11, 13, 29, 38), nNOS has
been shown to compensate for reduced NO and thereby restore
normal NO-dependent dilation in eNOS knockout mice (36,
37). In addition, some investigators have presented evidence
that the specific inhibitor of nNOS, 7-nitro indazole, reduces
the dilation of the basilar artery to acetylcholine (7). Nonethe-
less, our results indicate that endothelium-linked dilator re-
sponses are dramatically reduced by a single exposure of 300
l perivascular hemolysate and that this impaired dilation is
greater in ZO than in ZL rats. The sodium nitroprusside
response was not significantly different in the ZO compared
with the ZL rats and was not affected by a single hemolysate
injection. This finding suggests that dilation to NO donors is
not severely compromised by SAH in IR. Based on previous
observations from our laboratory, it is known that the response
to sodium nitroprusside remains intact in IR rats (19, 20). A
previous study on isolated canine basilar arteries after double
injection of blood into the cisterna magna showed that besides
reduced sGC expression and lower cyclic guanosine mono-
phosphate production, the response to sodium nitroprusside is
preserved via Ca2-activated K channels (40). Despite this,
we found that the function of these channels is impaired in IR
rats (16, 18). It is important to note, however, that because of
the low statistical power of our sodium nitroprusside re-
sponses, it is possible that using a different dose of sodium
nitroprusside, applying repeated rather than only one hemoly-
sate injection or making measurements at a later time period,
Fig. 4. Sodium nitroprusside (107 M) response of the BA (A) and its side
branch (B) 24 h after intracisternal hemolysate or saline injection in ZO and ZL
rats. Data are expressed as percent changes from baseline diameter (means 
SE). LS (n  8), LB (n  7), OS (n  10), and OB (n  7) groups are shown.
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might show a significant reduction in sodium nitroprusside
response in the ZO rats after SAH.
The KATP channel-activated dilation with cromakalim was
not preserved or enhanced after SAH, as previously described
(48, 49) in normal rats, but was rather reduced in both ZO and
ZL rats. The decrease in vascular reactivity was significantly
greater in the ZO than in the ZL rats. Similar results were
obtained from the measurement of side branch reactivity, but
the extent of vascular dysfunction was more moderate. These
findings suggest that the impairment of vascular responses to
KATP channel activators by the hemolysate injection is more
severe in major cerebral vessels than in smaller cerebral arter-
ies. Whereas most K channel-mediated responses are im-
paired after SAH except for the KATP channels, which are
selectively enhanced, the pharmacological activation of the
KATP channel with either endogenous substances or synthetic
analogs is a favorable approach to treat cerebral vasospasm (1,
30, 39, 51, 52, 58). Although we did not directly test KATP
channel function on vasospastic vessels, these therapies might
be of lower efficacy in the presence of IR based on our data.
The mechanism of KATP channel dysfunction in IR is most
likely related to the effect of enhanced reactive oxygen species
production (9, 18, 19).
No difference was observed between the baseline COX-2
expression of LS and OS, whereas COX-2 expression in-
creased dramatically in the OB but not in the LB group. The
elevation of COX-2 in the cerebral arteries after SAH has been
previously described (42, 43, 53). COX-2 produces a variety of
vasoactive prostanoids as well as superoxide anion that may
have affected the baseline diameter as well as the responsive-
ness of the basilar artery to both acetylcholine and cromakalim.
It appears that a higher expression of COX-2 could be a
prominent source of oxygen radicals in the basilar artery during
a more moderate exposure to perivascular hemolysate. Further
experiments are needed to determine whether the elevated level
of COX-2 is correlated with enhanced enzyme function or the
higher expression is a compensation for the lower availability
of substrates (arachidonic acid and O2). We have previously
shown in newborn pigs that superoxide anion generation re-
lated to COX-2 activation is a remarkable factor in producing
reduced dilator responses in the cerebral circulation (5). In
conclusion, COX-2 may represent a pivotal factor in exagger-
ating the cerebrovascular dysfunction of the basilar artery and
the side branch to SAH.
Perspective. Vasospasm represents a well-known, dangerous
situation for patients following SAH, but the consequences of
perivascular blood before the development of vasospasm are
not fully known. Our findings suggest that in this “quiet
period” in which blood products are in contact with the exterior
of cerebral arteries, before the appearance of vasospasm, the
cerebral arteries are already exhibiting reduced responsiveness
to both endothelium-dependent and -independent dilator stim-
uli. Thus the mere presence of perivascular blood products in
the absence of confounding variables such as increased intra-
cranial pressure has the potential to impair neurological func-
tion by causing an uncoupling between metabolic demand and
Fig. 5. Western blots showing the expression of endothelial nitric oxide (NO)
synthase (eNOS; 140 kDa; A), neuronal NO synthase (nNOS; B), and cyclo-
oxygenase-2 (COX-2; 72 kDa; C) enzymes in the major cerebral arteries 28 h
following intracisternal hemolysate or saline injection to ZO and ZL (n 3–5)
rats. -Actin was used as an internal control. nNOS immunoblots show both
nNOS (149 kDa) and nNOS (160 kDa) isoforms, but only the bands for
nNOS were evaluated. LS (n  3), LB (n  4), OS (n  3), and OB (n 
4) groups are shown. *P  0.05, blood vs. saline; #P  0.05, obese vs. lean.
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cerebral hemodynamics. Furthermore, existing metabolic dis-
eases such as IR are able to exaggerate cerebral vascular
dysfunction in SAH, likely because of the mechanisms involv-
ing enhanced vascular expression of COX-2. Finally, future
clinical studies should pay attention to the presence of IR and
metabolic syndrome in the outcome and complications of SAH
in patients.
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